Nitric oxide synthase modulates the antihyperalgesic effect of the NMDA receptor antagonist MK-801 on carrageenan-induced infammatory pain in rats

Tohoku Journal of Experimental Medicine

Volumn 234, Issue 4, 2014, Pages 287-293

  Srebro, Dragana P ^a   Vucković, Sonja M ^a   Savic Vujovic, Katarina R ^a   Prostran, Milica S ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Carrageenan; Mechanical hyperalgesia; MK 801; Nitric oxide; Rat

Indexed keywords

DIZOCILPINE; N NITRO ARGININE METHYL ESTER HYDROCHLORIDE; N OMEGA PROPYL ARGININE HYDROCHLORIDE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; S METHYLISOTHIOUREA; UNCLASSIFIED DRUG; ARGININE; CARRAGEENAN; DIZOCILPINE MALEATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N(G) NITROARGININE METHYL ESTER; N(OMEGA)-PROPYLARGININE; NITRIC OXIDE SYNTHASE; S-METHYLISOTHIOPSEUDOURONIUM; THIOUREA DERIVATIVE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERALGESIA ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG DOSE COMPARISON; DRUG POTENTIATION; ENZYME REGULATION; HYPERALGESIA; MALE; MECHANICAL STIMULATION; NEUROMODULATION; NOCICEPTION; NONHUMAN; PAIN; PAIN THRESHOLD; PREMEDICATION; RAT; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; COMPLICATION; DRUG EFFECTS; ENZYMOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; WISTAR RAT;

ANIMALS; ARGININE; CARRAGEENAN; DIZOCILPINE MALEATE; HYPERALGESIA; INFLAMMATION; ISOTHIURONIUM; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PAIN; PAIN THRESHOLD; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84919340629     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.234.287     Document Type: Article

References (54)

1. Andreasen, J.T., Bach, A., Gynther, M., Nasser, A., Mogensen, J., Strømgaard, K. & Pickering, D.S. (2013) UCCB01-125, a dimeric inhibitor of PSD-95, reduces inflammatory pain without disrupting cognitive or motor performance: comparison with the NMDA receptor antagonist MK-801. Neuro-pharmacology, 67, 193-200.
2. Begon, S., Pickering, G., Eschalier, A. & Dubray, C. (2000) Magnesium and MK-801 have a similar effect in two experimental models of neuropathic pain. Brain Res., 887, 436-439.
3. Berrino, L., Oliva, P., Massimo, F., Aurilio, C., Maione, S., Grella, A. & Rossi, F. (2003) Antinociceptive effect in mice of intra-peritoneal N-methyl-D-aspartate receptor antagonists in the formalin test. Eur. J. Pain, 7, 131-137.
4. Boettger, M.K., Uceyler, N., Zelenka, M., Schmitt, A., Reif, A., Chen, Y. & Sommer, C. (2007) Differences in infammatory pain in nNOS-, iNOS- and eNOS-defcient mice. Eur. J. Pain, 11, 810-818.
5. Boyce, S., Wyatt, A., Webb, J.K., O’Donnell, R., Mason, G., Rigby, M., Sirinathsinghji, D., Hill, R.G. & Rupniak, N.M. (1999) Selective NMDA NR2B antagonists induce antinoci-ception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn. Neuropharma-cology, 38, 611-623.
6. Calabrese, V., Mancuso, C., Calvani, M., Rizzarelli, E., Butterfeld, D.A. & Stella, A.M. (2007) Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat. Rev. Neurosci., 8, 766-775.
7. Carey, R.J., Dai, H. & Gui, J. (1998) Effects of dizocilpine (MK-801) on motor activity and memory. Psychopharma-cology (Berl), 137, 241-246.
8. Cavalcante, A.L., Siqueira, R.M., Araujo, J.C., Gondim, D.V., Ribeiro, R.A., Quetz, J.S., Havt, A., Lima, A.A. & Vale, M.L. (2013) Role of NMDA receptors in the trigeminal pathway, and the modulatory effect of magnesium in a model of rat temporomandibular joint arthritis. Eur. J. Oral Sci., 121, 573-583.
9. Chen, Z., Muscoli, C., Doyle, T., Bryant, L., Cuzzocrea, S., Mollace, V., Mastroianni, R., Masini, E. & Salvemini, D. (2010) NMDA-receptor activation and nitroxidative regulation of the glutamatergic pathway during nociceptive processing. Pain, 149, 100-106.
10. Chu, Y.C., Guan, Y., Skinner, J., Raja, S.N., Johns, R.A. & Tao, Y.X. (2005) Effect of genetic knockout or pharmacologic inhibition of neuronal nitric oxide synthase on complete Freund’s adjuvant-induced persistent pain. Pain, 119, 113-123.
11. Davidson, E.M., Coggeshall, R.E. & Carlton, S.M. (1997) Peripheral NMDA and non-NMDA glutamate receptors contribute to nociceptive behaviors in the rat formalin test. Neuroreport, 8, 941-946.
12. Dawson, V.L., Dawson, T.M., London, E.D., Bredt, D.S. & Snyder, S.H. (1991) Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA, 15, 6368-6371.
13. De Alba, J., Clayton, N.M., Collins, S.D., Colthup, P., Chessell, I. & Knowles, R.G. (2006) GW274150, a novel and highly selective inhibitor of the inducible isoform of nitric oxide synthase (iNOS), shows analgesic effects in rat models of inflammatory and neuropathic pain. Pain, 120, 170-181.
14. Dhir, A. & Kulkarni, S.K. (2008) Possible involvement of nitric oxide (NO) signaling pathway in the antidepressant-like effect of MK-801(dizocilpine), a NMDA receptor antagonist in mouse forced swim test. Indian J. Exp. Biol., 46, 164-170.
15. Du, J., Zhou, S., Coggeshall, R.E. & Carlton, S.M. (2003) N-methyl-D-aspartate-induced excitation and sensitization of normal and inflamed nociceptors. Neuroscience, 118, 547-562.
16. Freire, M.A. (2012) Pathophysiology of neurodegeneration following traumatic brain injury. West Indian Med. J., 61, 751-755.
17. Freire, M.A., Guimarães, J.S., Leal, W.G. & Pereira, A. (2009) Pain modulation by nitric oxide in the spinal cord. Front. Neurosci., 3, 175-181.
18. Gong, N., Gao, Z.Y., Wang, Y.C., Li, X.Y., Huang, J.L., Hashimoto, K. & Wang, Y.X. (2011) A series of D-amino acid oxidase inhibitors specifcally prevents and reverses formalin-induced tonic pain in rats. J. Pharmacol. Exp. Ther., 336, 282-293.
19. Hama, A., Woon Lee, J. & Sagen, J. (2003) Differential effcacy of intrathecal NMDA receptor antagonists on inflammatory mechanical and thermal hyperalgesia in rats. Eur. J. Pharmacol., 459, 49-58.
20. Hamza, M., Wang, X.M., Wu, T., Brahim, J.S., Rowan, J.S. & Dionne, R.A. (2010) Nitric oxide is negatively correlated to pain during acute infammation. Mol. Pain, 6, 55.
21. Holtman, J.R. Jr., Crooks, P.A., Johnson-Hardy, J.K., Hojomat, M., Kleven, M. & Wala, E.P. (2008) Effects of norketamine enan-tiomers in rodent models of persistent pain. Pharmacol. Biochem. Behav., 90, 676-685.
22. Im, D.S., Jeon, J.W., Lee, J.S., Won, S.J., Cho, S.I., Lee, Y.B. & Gwag, B.J. (2012) Role of the NMDA receptor and iron on free radical production and brain damage following transient middle cerebral artery occlusion. Brain Res., 1455, 114-123.
23. Infante, C., Díaz, M., Hernández, A., Constandil, L. & Pelissier, T. (2007) Expression of nitric oxide synthase isoforms in the dorsal horn of monoarthritic rats: effects of competitive and uncompetitive N-methyl-D-aspartate antagonists. Arthritis Res. Ther., 9, R53.
24. Jackson, D.L., Graff, C.B., Richardson, J.D. & Hargreaves, K.M. (1995) Glutamate participates in the peripheral modulation of thermal hyperalgesia in rats. Eur. J. Pharmacol., 284, 321-325.
25. Jeong, H.Y., Kim, J.Y., Lee, H.K., Ha do, T., Song, K.S., Bae, K. & Seong, Y.H. (2010) Leaf and stem of Vitis amurensis and its active components protect against amyloid β protein (25-35)-induced neurotoxicity. Arch. Pharm. Res., 33, 1655-1664.
26. Kawabata, A., Manabe, S., Manabe, Y. & Takagi, H. (1994) Effect of topical administration of L-arginine on formalin-induced nociception in the mouse: a dual role of peripherally formed NO in pain modulation. Br. J. Pharmacol., 112, 547-550.
27. Kawamata, T. & Omote, K. (1999) Activation of spinal N-methyl-D-aspartate receptors stimulates a nitric oxide/cyclic guano-sine 3,5-monophosphate/glutamate release cascade in nocicep-tive signaling. Anesthesiology, 91, 1415-1424.
28. Kawamata, T., Omote, K., Sonoda, H., Kawamata, M. & Namiki, A. (2000) Analgesic mechanisms of ketamine in the presence and absence of peripheral infammation. Anesthesiology, 93, 520-528.
29. Kovacic, P. & Somanathan, R. (2010) Clinical physiology and mechanism of dizocilpine (MK-801): electron transfer, radicals, redox metabolites and bioactivity. Oxid. Med. Cell. Longev., 3, 13-22.
30. Lawand, N.B., McNearney, T. & Westlund, K.N. (2000) Amino acid release into the knee joint: key role in nociception and infammation. Pain, 86, 69-74.
31. Lawand, N.B., Willis, W.D. & Westlund, K.N. (1997) Excitatory amino acid receptor involvement in peripheral nociceptive transmission in rats. Eur. J. Pharmacol., 324, 169-177.
32. More, A.S., Kumari, R.R., Gupta, G., Lingaraju, M.C., Balaganur, V., Pathak, N.N., Kumar, D., Kumar, D., Sharma, A.K. & Tandan, S.K. (2013) Effect of iNOS inhibitor S-methyliso-thiourea in monosodium iodoacetate-induced osteoathritic pain: implication for osteoarthritis therapy. Pharmacol. Biochem. Behav., 103, 764-772.
33. Olney, J.W., Labruyere, J. & Price, M.T. (1989) Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science, 244, 1360-1362.
34. O’Mahony, D. & Kendall, M.J. (1999) Nitric oxide in acute isch-aemic stroke: a target for neuroprotection. J. Neurol. Neuro-surg. Psychiatry, 67, 1-3.
35. Payne, J.E., Bonnefous, C., Symons, K.T., Nguyen, P.M., Sablad, M., Rozenkrants, N., Zhang, Y., Wang, L., Yazdani, N., Shiau, A.K., Noble, S.A., Rix, P., Rao, T.S., Hassig, C.A. & Smith, N.D. (2010) Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-((2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) part 2: identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNOS dimerization inhibitors that are orally active in pain models. J. Med. Chem., 53, 7739-7755.
36. Petrenko, A.B., Yamakura, T., Baba, H. & Shimoji, K. (2003) The role of N-methyl-D-aspartate (NMDA) receptors in pain: a review. Anesth. Analg., 97, 1108-1116.
37. Ren, K., Hylden, J.L., Williams, G.M., Ruda, M.A. & Dubner, R. (1992a) The effects of a non-competitive NMDA receptor antagonist, MK-801, on behavioral hyperalgesia and dorsal horn neuronal activity in rats with unilateral inflammation. Pain, 50, 331-344.
38. Ren, K., Williams, G.M., Hylden, J.L., Ruda, M.A. & Dubner, R. (1992b) The intrathecal administration of excitatory amino acid receptor antagonists selectively attenuated carrageenan-induced behavioral hyperalgesia in rats. Eur. J. Pharmacol., 219, 235-243.
39. Romero, T.R., Galdino, G.S., Silva, G.C., Resende, L.C., Perez, A.C., Côrtes, S.F. & Duarte, I.D. (2011) Ketamine activates the L-arginine/Nitric oxide/cyclic guanosine monophosphate pathway to induce peripheral antinociception in rats. Anesth. Analg., 113, 1254-1259.
40. Rung, J.P., Carlsson, A., Rydén Markinhuhta, K. & Carlsson, M.L. (2005) (+)-MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophrenia. Prog. Neuro-psychopharmacol. Biol. Psychiatry, 29, 827-832.
41. Schmidtko, A., Tegeder, I. & Geisslinger, G. (2009) No NO, no pain? The role of nitric oxide and cGMP in spinal pain processing. Trends Neurosci., 32, 339-346.
42. Srebro, D.P., Vučković, S., Vujović, K.S. & Prostran, M. (2014) Anti-hyperalgesic effect of systemic magnesium sulfate in carrageenan-induced inflammatory pain in rats: influence of the nitric oxide pathway. Magnes. Res., 27, 77-85.
43. Suetake-Koga, S., Shimazaki, T., Takamori, K., Chaki, S., Kanuma, K., Sekiguchi, Y., Suzuki, T., Kikuchi, T., Matsui, Y. & Honda, T. (2006) In vitro and antinociceptive profle of HON0001, an orally active NMDA receptor NR2B subunit antagonist. Pharmacol. Biochem. Behav., 84, 134-141.
44. Tanabe, M., Nagatani, Y., Saitoh, K., Takasu, K. & Ono, H. (2009) Pharmacological assessments of nitric oxide synthase isoforms and downstream diversity of NO signaling in the maintenance of thermal and mechanical hypersensitivity after peripheral nerve injury in mice. Neuropharmacology, 56, 702-708.
45. Tang, Q., Svensson, C.I., Fitzsimmons, B., Webb, M., Yaksh, T.L. & Hua, X.Y. (2007) Inhibition of spinal constitutive NOS-2 by 1400W attenuates tissue injury and infammation-induced hyperalgesia and spinal p38 activation. Eur. J. Neurosci., 25, 2964-2972.
46. Tao, F., Tao, Y.X., Zhao, C., Dore, S., Liaw, W.J., Raja, S.N. & Johns, R.A. (2004) Differential roles of neuronal and endo-thelial nitric oxide synthases during carrageenan-induced infammatory hyperalgesia. Neuroscience, 128, 421-430.
47. Togashi, H., Sasaki, M., Frohman, E., Taira, E., Ratan, R.R., Dawson, T.M. & Dawson, V.L. (1997) Neuronal (type I) nitric oxide synthase regulates nuclear factorκB activity and immu-nologic (type II) nitric oxide synthase expression. Proc. Natl. Acad. Sci. USA, 94, 2676-2680.
48. Vaccarino, A.L., Marek, P., Kest, B., Weber, E., Keana, J.F. & Liebeskind, J.C. (1993) NMDA receptor antagonists, MK-801 and ACEA-1011, prevent the development of tonic pain following subcutaneous formalin. Brain Res., 615, 331-334.
49. Vezzani, A., Serafni, R., Stasi, M.A., Caccia, S., Conti, I., Tridico, R.V. & Samanin, R. (1989) Kinetics of MK-801 and its effect on quinolinic acid-induced seizures and neurotoxicity in rats. J. Pharmacol. Exp. Ther., 249, 278-283.
50. Wang, Q., Li, J., Wei, X., Liao, J., Xu, Y., Lu, T., Qin, B., Xie, J., Deng, C. & Huang, X. (2014) Alterations of NMDA receptor binding in various brain regions among 6-hydroxydopamine-induced Parkinsonian rats. Int. J. Neurosci., 124, 457-465.
51. Xie, Q.W., Whisnant, R. & Nathan, C. (1993) Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J. Exp. Med., 177, 1779-1784.
52. Yamamoto, T. & Yaksh, T.L. (1992) Comparison of the antinoci-ceptive effects of pre- and posttreatment with intrathecal morphine and MK801, an NMDA antagonist, on the formalin test in the rat. Anesthesiology, 77, 757-763.
53. Yonehara, N., Amano, K. & Kamisaki, Y. (2002) Involvement of the NMDA-nitric oxide pathway in the development of hyper-sensitivity to tactile stimulation in dental injured rats. Jpn. J. Pharmacol., 90, 145-155.
54. Zhang, X.C., Zhang, Y.Q. & Zhao, Z.Q. (2006) Different roles of two nitric oxide activated pathways in spinal long-term poten-tiation of C-fiber-evoked field potentials. Neuropharma-cology, 50, 748-754.